{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-secondary-use-of-clinical-trial-data-research-sharing”
},
“headline”: “SOP for Secondary Use of Clinical Trial Data (Research Sharing)”,
“description”: “This SOP defines procedures for the secondary use of clinical trial data, including governance for research sharing, anonymization, repositories submission, and compliance with FDA, EMA, CDSCO, WHO, GDPR, HIPAA, and ICH GCP guidelines.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}
Published on 21/12/2025
Standard Operating Procedure for Secondary Use of Clinical Trial Data (Research Sharing)
| SOP No. | CR/OPS/127/2025 |
| Supersedes | NA |
| Page No. | 1 of 69 |
| Issue Date | 26/08/2025 |
| Effective Date | 01/09/2025 |
| Review Date | 01/09/2026 |
Purpose
The purpose of this SOP is to establish governance and procedures for the secondary use of clinical trial data,
Scope
This SOP applies to sponsors, investigators, CROs, regulatory affairs teams, and data managers engaged in sharing or reusing clinical trial data for secondary purposes. It covers consent, anonymization, governance, repository submission, subject rights, data retention, and regulatory inspection readiness.
Responsibilities
- Sponsor: Oversees data sharing strategy, ensures data anonymization, and compliance with global data sharing policies.
- Investigator: Ensures subject consent allows secondary data use and provides trial-specific context for reuse.
- CRO: Monitors and supports data anonymization and submission processes.
- Data Manager: Prepares datasets, applies quality checks, and ensures secure transfer.
- QA: Audits secondary use data processes and maintains inspection readiness.
- Data Protection Officer: Ensures GDPR/HIPAA compliance and manages subject rights requests.
Accountability
The Sponsor’s Data Governance Lead is accountable for ensuring compliance with secondary use of data governance. Data Managers are accountable for the integrity of anonymized data sets.
Procedure
1. Consent and Governance
1.1 Confirm subject consent includes provisions for secondary use of data.
1.2 Document in Secondary Use Consent Log (Annexure-1).
2. Anonymization and Pseudonymization
2.1 Remove personal identifiers from datasets.
2.2 Apply pseudonymization techniques where necessary.
2.3 Record in Data Anonymization Log (Annexure-2).
3. Data Preparation and Quality Checks
3.1 Extract datasets required for secondary analysis.
3.2 Apply quality control checks to ensure accuracy.
3.3 Record in Data Preparation Log (Annexure-3).
4. Repository Submission
4.1 Submit anonymized datasets to regulatory or research repositories (e.g., ClinicalStudyDataRequest, WHO ICTRP).
4.2 Maintain Repository Submission Log (Annexure-4).
5. Subject Rights
5.1 Respond to subject requests for access, withdrawal, or deletion of data.
5.2 Record in Subject Rights Log (Annexure-5).
6. Data Security
6.1 Transfer data using secure encrypted channels.
6.2 Store shared data in validated systems.
6.3 Record in Data Security Log (Annexure-6).
7. Archiving
7.1 Archive secondary use datasets, anonymization records, and submission documents in TMF and ISF.
7.2 Retain per global regulatory timelines.
Abbreviations
- SOP: Standard Operating Procedure
- CRO: Contract Research Organization
- QA: Quality Assurance
- DPO: Data Protection Officer
- ISF: Investigator Site File
- TMF: Trial Master File
- GDPR: General Data Protection Regulation
- HIPAA: Health Insurance Portability and Accountability Act
- FDA: Food and Drug Administration
- EMA: European Medicines Agency
- CDSCO: Central Drugs Standard Control Organization
- WHO: World Health Organization
Documents
- Secondary Use Consent Log (Annexure-1)
- Data Anonymization Log (Annexure-2)
- Data Preparation Log (Annexure-3)
- Repository Submission Log (Annexure-4)
- Subject Rights Log (Annexure-5)
- Data Security Log (Annexure-6)
References
- FDA – Data Sharing and Standards
- EMA – Clinical Data Publication
- CDSCO – Clinical Data Sharing Rules
- WHO – Clinical Trials Data Sharing Policy
- ICH GCP – Data Transparency Standards
Version: 1.0
Approval Section
| Prepared By | Ravi Kumar, Data Governance Specialist |
| Checked By | Sunita Reddy, QA Officer |
| Approved By | Dr. Anil Sharma, Head Clinical Operations |
Annexures
Annexure-1: Secondary Use Consent Log
| Date | Subject ID | Consent Obtained | Investigator | Status |
|---|---|---|---|---|
| 01/09/2025 | D101 | Yes | PI | Signed |
Annexure-2: Data Anonymization Log
| Date | Dataset | Method | Performed By | Status |
|---|---|---|---|---|
| 02/09/2025 | D101-Labs | Pseudonymization | Data Manager | Completed |
Annexure-3: Data Preparation Log
| Date | Dataset | QC Check | Performed By | Status |
|---|---|---|---|---|
| 03/09/2025 | D101-Labs | Accuracy | Data Manager | Valid |
Annexure-4: Repository Submission Log
| Date | Dataset | Repository | Submitted By | Status |
|---|---|---|---|---|
| 04/09/2025 | D101-Labs | WHO ICTRP | Regulatory Affairs | Submitted |
Annexure-5: Subject Rights Log
| Date | Subject ID | Request Type | Action Taken | Status |
|---|---|---|---|---|
| 05/09/2025 | D101 | Withdrawal | Dataset Removed | Closed |
Annexure-6: Data Security Log
| Date | System | Security Measure | Reviewed By | Status |
|---|---|---|---|---|
| 06/09/2025 | Repository Server | AES-256 Encryption | IT Security | Compliant |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
|---|---|---|---|---|
| 26/08/2025 | 00 | Initial version | New SOP creation | Head Clinical Operations |
For more SOPs visit: Pharma SOP